The Role of CDK 4/6 Inhibitors in Advanced Breast Cancer

The Role of CDK 4/6 Inhibitors in Advanced Breast Cancer
Don Photo

Don
3 años 73 Visitas
Categoría:
Descripción:
Debra Patt, MD, Executive Vice President, Strategic Initiatives, Academic Programs, Texas Oncology explains the role of CDK 4/6 inhibitors in advanced breast cancer and discusses whether they are interchangeable in treatment planning for patients.